Impact of incomplete surgery and adjuvant chemotherapy for the intraoperative rupture of capsulated stage I epithelial ovarian cancer: a multi-institutional study with an in-depth subgroup analysis-Reference-Cited by-同舟云学术

Impact of incomplete surgery and adjuvant chemotherapy for the intraoperative rupture of capsulated stage I epithelial ovarian cancer: a multi-institutional study with an in-depth subgroup analysis

Published:2021 Issue:5 Volume:32 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Yoshihara Masato¹^ORCID,Tamauchi Satoshi¹^ORCID,Iyoshi Shohei¹²^ORCID,Kitami Kazuhisa¹^ORCID,Uno Kaname¹³^ORCID,Mogi Kazumasa¹^ORCID,Kajiyama Hiroaki¹^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

2. Institute for Surgical Pathology, University of Freiburg Faculty of Medicine, Freiburg im Breisgau, Germany.

3. Department of Laboratory Medicine, Lund University Faculty of Medicine, Lund, Sweden.

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://ejgo.org/pdf/10.3802/jgo.2021.32.e66

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of intraoperative rupture in early-stage epithelial ovarian cancer: an ancillary study of GORILLA-3002;European Journal of Surgical Oncology;2024-11

2. High-throughput viable circulating tumor cell isolation using tapered-slit membrane filter-based chipsets in the differential diagnosis of ovarian tumors;PLOS ONE;2024-06-04

3. Current Treatment Practices and Prognostic Factors in Early-Stage Ovarian Cancer—An Analysis of the NOGGO/JAGO;Cancers;2023-03-29

4. Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational study;International Journal of Gynecologic Cancer;2022-09-14

5. Is There a Survival Benefit of Adjuvant Chemotherapy in Stage IC1 Epithelial Ovarian Cancer Patients? A Meta-Analysis;Current Oncology;2022-08-15